PE Fund Investments
In Vitro Diagnostics firm Medsource Ozone raises $4.7 M from Xponentia Capital
Faridabad-based In Vitro Diagnostics (IVD) manufacturer Medsource Ozone Biomedicals has raised INR 35 Cr ($4.7 M) in an equity round from Xponentia Capital (via Xponentia Opportunities Fund 1). Xponentia Capital subscribed to 95,803 equity shares at an issue price of INR 3,653.33. Regulatory filings also show a secondary transfer of 13,686 equity shares from the promoters. Xponentia will hold 6.9% stake in the company post the transaction. Medsource Ozone had reported a turnover of INR 78.18 Cr in the last fiscal year. Its EBITDA and PAT values stood at INR 10.30 Cr and INR 6.89 Cr respectively.
Want to receive such news items in your inbox? Click Here to sign up for a trial.
